Company Overview
More
Longsheng Pharmaceutical Holdings Co., Ltd. is a Hong Kong investment holding company mainly engaged in pharmaceutical business. The company operates through three major divisions. The specialist Pharmaceutical Division is engaged in the development, production and sales of specialized drugs in the field of rheumatism and dermatology. Its core specialist drugs include parvlin, leflunomide tablets and mycophenolate mofetil dispersible tablets. Plant extraction and Health products Division is engaged in the development, production and sales of traditional Chinese medicine extracts and health products. Other pharmaceutical branches are engaged in other drug-related business.
CEO： Zhentao Wu
Market： Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
00503 LANSEN PHARMA
1.040-0.010-0.95%
Closed 05/20 16:08 CCT
High
1.080
Open
1.050
Turnover
26.29K
Low
1.040
Pre Close
1.050
Volume
25.00K
Price Forecast
No Data
News
Comment
LANSEN PHARMA: 2021 ANNUAL REPORT
LANSEN PHARMA: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2021
LANSEN PHARMA: DATE OF BOARD MEETING
LANSEN PHARMA: ANNOUNCEMENT ON ESTIMATED PROFIT DECREASE FOR THE YEAR ENDED 31 DECEMBER 2021
LANSEN PHARMA: 2021 INTERIM REPORT
LANSEN PHARMA: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2021, SPECIAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS
LANSEN PHARMA: DATE OF BOARD MEETING
LANSEN PHARMA: SUPPLEMENTAL ANNOUNCEMENT ON ESTIMATED PROFIT DECREASE FOR THE SIX MONTHS ENDED 30 JUNE 2021
LANSEN PHARMA: ANNOUNCEMENT ON ESTIMATED PROFIT DECREASE FOR THE SIX MONTHS ENDED 30 JUNE 2021
LANSEN PHARMA: 2020 ANNUAL REPORT